Targeted Genetics Corp /WA/ - Current report filing (8-K)
31 1월 2008 - 7:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported):
January
11, 2008
Targeted
Genetics Corporation
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Washington
|
|
0-23930
|
|
91-1549568
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1100
Olive Way, Suite 100, Seattle, Washington
|
|
98101
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code
|
|
(206) 623-7612
|
(Former
name or former address if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item
8.01. Other Events.
On
January 11, 2008, at the special meeting of the shareholders of Targeted
Genetics Corporation, or the Company, the Company’s shareholders approved
proposed amendments to the Company’s Amended and Restated Articles of
Incorporation as amended to increase the Company’s authorized common stock from
30,000,000 shares to 45,000,000 shares and increase the Company’s authorized
preferred stock from 600,000 shares to 10,000,000 shares.
The
amendments were filed with the Washington State Secretary of State on January
24, 2008. Immediately following the filing of the amendments, the Company filed
a restatement of its Amended and Restated Articles as amended with the
Washington State Secretary of State. A copy of the Company’s Restated Articles
of Incorporation is filed as Exhibit 3.1 to this Current Report on Form 8-K
and
is incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits:
|
|
|
3.1
|
|
Restated
Articles of Incorporation of Targeted Genetics Corporation dated
January
23, 2008
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
TARGETED
GENETICS CORPORATION
|
|
|
|
Dated:
January 30, 2008
|
By:
|
/s/
David J. Poston
|
|
David
J. Poston
Vice
President Finance and Chief Financial
Officer
|
INDEX
TO EXHIBITS
|
|
|
3.1
|
|
Restated
Articles of Incorporation of Targeted Genetics Corporation dated
January
23, 2008
|
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024